Verano Holdings (VRNO) Invested Capital (2021 - 2026)
Verano Holdings' (VRNO) quarterly Invested Capital came in at $156000.0 in Q1 2026, down 74.55% year-on-year from $613000.0 in Q1 2025, and down 42.22% on a QoQ basis from $270000.0 in Q4 2025.
Verano Holdings (VRNO) Invested Capital (2021 - 2026) Analysis & Trends
Verano Holdings (VRNO) has 6 years of Invested Capital data on file, last reported at $156000.0 in Q1 2026.
- On a quarterly basis, Invested Capital fell 74.55% year-over-year to $156000.0 in Q1 2026; TTM through Mar 2026 was $3.9 million, a 91.49% decrease from a year earlier, with the FY2025 full-year figure at $270000.0, down 98.51% from the prior year.
- Invested Capital for Q1 2026 stood at $156000.0, down from $270000.0 in the prior quarter.
- Over the last five years, Invested Capital for VRNO reached as high as $258.9 million in Q2 2022 and fell as low as -$4.8 million in Q1 2022.
- Historically, Invested Capital has averaged $28.3 million across 5 years, with a median of $6.7 million in 2023.
- Across the five-year window, Invested Capital soared 410.55% in 2023 and slumped 98.85% in 2025, its largest moves.
- Year by year, Invested Capital stood at $24.5 million in 2022, then sank by 84.0% to $3.9 million in 2023, then surged by 363.68% to $18.2 million in 2024, then plunged by 98.51% to $270000.0 in 2025, then sank by 42.22% to $156000.0 in 2026.
- Per Business Quant data, the three most recent Invested Capital figures were $156000.0 in Q1 2026, $270000.0 in Q4 2025, and $2.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 1.11 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 2.61 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 31.13 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 7.15 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.93 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 73.00 Mn |
| 10 | Verano Holdings | 2.02 Bn | 1.94 Bn | 98.98 Mn | 156,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 156,000.00 |
| Dec 31, 2025 | 270,000.00 |
| Sep 30, 2025 | 2.94 Mn |
| Jun 30, 2025 | 499,000.00 |
| Mar 31, 2025 | 613,000.00 |
| Dec 31, 2024 | 18.15 Mn |
| Sep 30, 2024 | 22.53 Mn |
| Jun 30, 2024 | 4.06 Mn |
| Mar 31, 2024 | 53.41 Mn |
| Dec 31, 2023 | 3.92 Mn |
| Sep 30, 2023 | 6.70 Mn |
| Jun 30, 2023 | 21.43 Mn |
| Mar 31, 2023 | 14.78 Mn |
| Dec 31, 2022 | 24.46 Mn |
| Sep 30, 2022 | 53.74 Mn |
| Jun 30, 2022 | 258.88 Mn |
| Mar 31, 2022 | -4.76 Mn |
| Dec 31, 2021 | 208.35 Mn |